Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Merck & Co., Inc.
Form 13F · Q2 2026

Merck & Co., Inc.

CIK 310158Filed 2026-08-0713F-HR View the filing on EDGAR ↗
$526M
Reported book value
13
Positions
7
Quarters on record
Top 50
Positions

Merck & Co., Inc. — holdings

Top 13 positions of 13, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PSNL Personalis Inc14.0M+0.0%$188M35.8%
2MRNA Moderna Inc2.3M+0.0%$162M30.7%
3KYMR Kymera Therapeutics Inc772,165+0.0%$89M16.8%
4AKTS Aktis Oncology Inc952,844+0.0%$31M5.8%
5EIKN Eikon Therapeutics Inc1.7M+0.0%$22M4.1%
6TRDA Entrada Therapeutics Inc1.7M—$13M2.4%
7STRO Sutro Biopharma Inc272,351—$9M1.7%
8ALEC Alector Inc3.5M+0.0%$7M1.4%
9EVAX Evaxion Biotech A/S1.2M—$4M0.7%
10VRDN Viridian Therapeutics Inc93,414+0.0%$2M0.3%
11XLO Xilio Therapeutics Inc105,982+0.0%$1M0.2%
12HURA Tuhura Biosciences Inc19,445+0.0%$45,5010.0%
13NEUP Neuphoria Therapeutics Inc10,027+0.0%$43,8180.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.